Conversations with Experts Luncheons are an opportunity for all Summit attendees to join informal roundtable discussions focusing on all aspects of stem cells and regenerative medicine, including science, business, public policy, social, ethical, education, advocacy and commercialization strategies. This luncheon is a unique opportunity to build strategic relationships and have your questions answered.
Content and information will be updated as programming details are finalized. Sign up to receive alerts when new information is available.
Examples of Expert Luncheons from 2011:
Science & Industry
“MSC's in clinical trials: delivering effective therapies”
Arnold Caplan, PhD, Professor of Biology and General Medical Sciences, Case Western Reserve University
“IPS Technologies: Positives and Negatives”
James Eliason, PhD, Director, Stem Cell Commercialization Center, Tech Town, Wayne State University
“Overcoming the Obstacles to Growing Whole Organs”
Tracy Grikscheit, MD, Assistant Professor of Surgery, Children’s Hospital Los Angeles
“Amniotic Fluid Stem Cells”
Laura Perin, PhD
Assistant Professor Urology, Children’s Hospital Los Angeles
"The critical role of stem cells in toxicity studies"
Prue Talbot, Professor of Cell Biology, Director, UCR Stem Cell Center and Stem Cell Core Facility
“The important clinical implications of parthenogenetic stem cell research”
Bill Adams, Co-founder, International Stem Cell Corporation
“Stem Cells in Drug Discovery and Toxicity Testing”
Dr. Knut Niss, Manager R&D, Stem Cell Initiative, EMD Millipore
“cGMP Manufacture of Stem Cells”
Bob Shaw, Commercial Director, Stem Cell Initiative, EMD Millipore
“Stem Cell Characterization and Assays”
Victor Koong, Product Manager - Stem Cells/Cell Biology, EMD Millipore
“Stem Cell Quality Assurance- Avoiding Early Stage Pitfalls.”
Rob Herrera, CEO, Cell Line Genetics
“Start-Up Nation- Research and Commercial Collaboration Opportunities in Israel”
Avi Treves,PhD and Amon Pelz, Sheba Medical Center and Taburit
“From Dolly to Dollars: Collaboration Opportunities in Scotland”
Kevin Price,CEO, Scottish Stem Cell Network
“Systematising the derivation of lineage-restricted stem cells”
Michael West, PhD, CEO, BioTime
“Bringing regenerative medicine to big business”
Stephen Minger, PhD, GE Healthcare
“Endogenous Stem Cells – Promise and Possibilities”
Paul Patterson, PhD, Caltech
“Cardiac regeneration in the zebra fish model- human implications”
Michael Harrison, PhD, Children’s Hospital Los Angeles
“Stem Cells Derived from Cord Blood- Expected Return on Investment.”
Claudia Zylberberg, PhD, CEO, Akron Biotech
“Current and Future Trends in the Regenerative Medicine Industry”
Lee Buckler, Managing Partner, Cell Therapy Group
“Business Models for Autologous Cell Therapy”
Elona Baum, JD, General Counsel, California Institute for Regenerative Medicine
"Pathways to a Skilled Stem Cell Workforce"
Pamela Eversole-Cire, Ph.D.
Director, Biological Technology Program, Pasadena City College
“Identifying the right partners for investment or acquisition”
Scott Burger, MD, Advanced Cell & Gene Therapy, LLC
“Industry Perspectives from the Alliance for Regenerative Medicine”
Robert Margolin
“Prospects for Regenerative Medicine Against Aging”
Aubrey de Grey, PhD, The SENS Foundation
Policy & Regulation
“Changing Landscape- NIH Funding for Biomedical Research.”
Max Bronstein, Manager of Science & Policy, Research!America
"International Challenges in Embryonic Stem Cell Science"
John Hearn, Chief Executive, Worldwide Universities Network
“Stem Cell Legislation Across the EU – Trends
Pitfalls and Opportunities for Academic Research and Industry”
Timo Faltus, Dip. Jur. Dipl. Biol., University of Leipzig
“Stem Cell Science and Regenerative Medicine in the Internet Cloud, Apps, and Social Media: the Ix in Rx/Dx/Px/Ix”
Alan Jakimo, MBA, JD, Partner, Sidley Austin, LLP
"Pointers on Interacting with the FDA on Cell Therapy Matters"
Steve Bauer, PhD
FDA, Division of Cellular and Gene Therapies
Patient Focus
“Stem Cell Action – Building National Advocacy Movement State by State”
Victoria Kohout, Executive Director, Nebraska Coalition for Life Saving Cures
“Parental Ethics and Funding Challenges in Pediatric Neurology Treatments”
Mary Schneider, Legislative Advocate, Children’s Neurobiological Solutions (CNS) Foundation
“Focus on Diabetes”
Meri Firpo, PhD, University of Minnesota Stem Cell Institute
“Focus on Spinal Cord Injury”
Sabrina Cohen, Executive Director, Sabrina Cohen Foundation for Stem Cell Research
“Focus on ALS”
Stephen Byer, Founder, ALS Worldwide
“Newmie from Baywatch and Svendsen from Cedars talk about Parkinson’s disease”
Michael Newman, Advocate and Clive Svendsen, Director, Cedars-Sinai Regenerative Medicine Institute
“The Untold Story of the Discovery of Stem Cells by Till & McCulloch”
Joe Sornberger, Author of "Dreams & Due Diligence – Till & McCulloch’s Stem Cell Discovery and Legacy" and James Price, CEO, Canadian Stem Cell Foundation
“Prospects for stem cell therapies for Parkinson's Disease”
Xianmin Zeng, PhD, Buck Institute for Aging Research
“Stem cell therapies for the lung”
David Warburton, MD, Children’s Hospital Los Angeles
